Victory Capital Management Inc. Has $50.76 Million Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Victory Capital Management Inc. boosted its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 4,432.8% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,621,593 shares of the company’s stock after purchasing an additional 1,585,818 shares during the period. Victory Capital Management Inc.’s holdings in Option Care Health were worth $50,756,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. UMB Bank n.a. raised its stake in shares of Option Care Health by 937.5% during the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock worth $26,000 after purchasing an additional 750 shares in the last quarter. GAMMA Investing LLC grew its stake in shares of Option Care Health by 110.6% in the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after buying an additional 471 shares in the last quarter. Whittier Trust Co. of Nevada Inc. increased its holdings in Option Care Health by 3,362.8% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after buying an additional 1,446 shares during the last quarter. SageView Advisory Group LLC bought a new stake in Option Care Health during the first quarter worth $85,000. Finally, International Assets Investment Management LLC lifted its stake in Option Care Health by 3,029.7% in the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after acquiring an additional 2,757 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Stock Up 0.0 %

OPCH opened at $22.19 on Friday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The stock has a fifty day moving average of $29.03 and a 200-day moving average of $29.49. Option Care Health, Inc. has a fifty-two week low of $22.04 and a fifty-two week high of $34.63. The company has a market capitalization of $3.78 billion, a P/E ratio of 18.65, a P/E/G ratio of 2.37 and a beta of 1.32.

Insider Activity at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of Option Care Health stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the transaction, the director now owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the transaction, the director now owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. This represents a 69.02 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.64% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on OPCH. Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. Truist Financial dropped their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. JMP Securities lifted their target price on Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research note on Monday, September 30th. Barrington Research dropped their price target on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research note on Thursday, October 31st. Finally, Bank of America cut shares of Option Care Health from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $43.00 to $29.00 in a research report on Wednesday, October 30th. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Option Care Health presently has an average rating of “Moderate Buy” and a consensus target price of $30.83.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.